{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:39:10Z","timestamp":1792708750830,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["A Health"],"award-info":[{"award-number":["A Health"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["Labour Sciences Research Grant"],"award-info":[{"award-number":["Labour Sciences Research Grant"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004206","name":"Osaka University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004206","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>In Japan, Japan\u2019s Ministry of Health, Labor, and Welfare decided to suspend govermental recommendation for HPV vaccination in FY 2013. The HPV vaccination rate for those born in FY 2000 or thereafter declined dramatically. In 2021, the \u201csuspension of recommendation\u201d ended. The catch-up vaccinations for the unvaccinated have been offered nationwide from FY 2022 to FY 2024. We aimed\u00a0to quantify the vaccination intentions and characteristics of those young women now eligible for catch-up vaccination.\u00a0<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In February of 2022, we conducted an internet survey\u00a0targeted women who were born in 1997\u20132004 but who had not yet been HPV vaccinated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We received 1,648 valid responses. 41.6% of the respondents wanted to uptake the catch-up HPV vaccination, 29.7% were undecided, and 28.7% did not want to be vaccinated. The intention to uptake catch-up HPV vaccination was associated with a good history of gynecological visits, intention to receive cervical cancer screening, sexual activity, degree of anxiety about cervical cancer, familiarity with problems associated with cervical cancer, experience with vaccination recommendations, and knowledge about cervical cancer (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05, respectively). In the vaccinated generation, the proportion of the group that did not want to be vaccinated was significantly higher (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). In the vaccine-suspended generation, the proportion of the group that wanted to be vaccinated was significantly higher (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our survey revealed that catch-up vaccination intentions differed depending on the vaccination environment.\u00a0It is necessary for all organizations involved with HPV vaccination, such as government, medical institutions, and educational institutions, to make recommendations based on an understanding of the characteristics of the \u201cvaccinated generation\u201d and the \u201cvaccine-suspended generation\u201d.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10147-023-02411-0","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T14:01:32Z","timestamp":1696082492000},"page":"1667-1679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Intentions for catch-up HPV vaccination in Japan: an internet survey"],"prefix":"10.1007","volume":"28","author":[{"given":"Satoshi","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3222-5963","authenticated-orcid":false,"given":"Asami","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Kakuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomio","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,30]]},"reference":[{"key":"2411_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pvr.2018.10.001","volume":"6","author":"J Sakamoto","year":"2018","unstructured":"Sakamoto J, Kamiura S, Okayama K et al (2018) Single type infection of human papillomavirus as a cause for high-grade cervical intraepithelial neoplasia and invasive cancer in Japan. Papillomavirus Res 6:46\u201351. https:\/\/doi.org\/10.1016\/j.pvr.2018.10.001","journal-title":"Papillomavirus Res"},{"key":"2411_CR2","doi-asserted-by":"publisher","first-page":"930","DOI":"10.5858\/2003-127-930-HPEAPH","volume":"127","author":"M Schiffman","year":"2003","unstructured":"Schiffman M, Castle PE (2003) Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 127:930\u2013934","journal-title":"Arch Pathol Lab Med"},{"issue":"Suppl 2","key":"2411_CR3","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1086\/342109","volume":"35","author":"DJ Wiley","year":"2002","unstructured":"Wiley DJ, Douglas J, Beutner K et al (2002) External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 35(Suppl 2):S210\u2013S224","journal-title":"Clin Infect Dis"},{"key":"2411_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel C, Plummer M, Vignat J et al (2017) Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 141:664\u2013670","journal-title":"Int J Cancer"},{"key":"2411_CR5","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1056\/NEJMoa053284","volume":"354","author":"RL Winer","year":"2006","unstructured":"Winer RL, Hughes JP, Feng Q et al (2006) Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 354:2645\u20132654","journal-title":"N Engl J Med"},{"key":"2411_CR6","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1158\/0008-5472.CAN-18-3109","volume":"79","author":"A Yagi","year":"2019","unstructured":"Yagi A, Ueda Y, Kakuda M et al (2019) Epidemiologic and clinical analysis of cervical cancer using data from the population-based osaka cancer registry. Cancer Res 79:1252\u20131259. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3109","journal-title":"Cancer Res"},{"key":"2411_CR7","unstructured":"Response to routine immunization against human papillomavirus infection (recommendation) 2013. The Ministry of Health, Labor and Welfare, Japan. Available online: https:\/\/www.mhlw.go.jp\/stf\/shingi2\/0000091963.html (accessed on 25 March 2023)."},{"issue":"9987","key":"2411_CR8","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1016\/S0140-6736(15)61152-7","volume":"385","author":"SJ Hanley","year":"2015","unstructured":"Hanley SJ, Yoshioka E, Ito Y et al (2015) HPV vaccination crisis in Japan. Lancet 385(9987):2571","journal-title":"Lancet"},{"key":"2411_CR9","unstructured":"World Health Organization, Global Advisory Committee on Vaccine Safety: Statement on Safety of HPV vaccines. 17 December 2015, https:\/\/www.who.int\/groups\/global-advisory-committee-on-vaccine-safety\/topics\/human-papillomavirus-vaccines\/safety (accessed on 25 March 2023)."},{"key":"2411_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100300","volume":"16","author":"M Sekine","year":"2021","unstructured":"Sekine M, Yamaguchi M, Kudo R et al (2021) Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data. Lancet Reg Health West Pac 16:100300","journal-title":"Lancet Reg Health West Pac"},{"key":"2411_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100327","volume":"18","author":"A Yagi","year":"2021","unstructured":"Yagi A, Ueda Y, Ikeda S et al (2021) The looming health hazard: A wave of HPV-related cancers in Japan is becoming a reality due to the continued suspension of the governmental recommendation of HPV vaccine. Lancet Reg Health West Pac 18:100327","journal-title":"Lancet Reg Health West Pac"},{"key":"2411_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2188\/jea.JE20210277","volume":"32","author":"W Fukushima","year":"2022","unstructured":"Fukushima W et al (2022) A nationwide epidemiological survey of adolescent patients with diverse symptoms similar to those following human papillomavirus vaccination: background prevalence and incidence for considering vaccine safety in Japan. J Epidemiol 32:34\u201343","journal-title":"J Epidemiol"},{"key":"2411_CR13","unstructured":"The 23rd Welfare Science Council Vaccination and Vaccine Subcommittee Side-Reaction Study Group. 26 December 2016. https:\/\/www.mhlw.go.jp\/stf\/shingi2\/0000147015.html Available online. (Accessed on 25 March 2023)."},{"key":"2411_CR14","unstructured":"The 26th Welfare Science Council Vaccination and Vaccine Subcommittee Side-Reaction Study Group. 10 April 2017. Available online: https:\/\/www.mhlw.go.jp\/stf\/shingi2\/0000161332.html (Accessed on 25 March 2023)."},{"key":"2411_CR15","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1111\/cas.14406","volume":"111","author":"S Nakagawa","year":"2020","unstructured":"Nakagawa S et al (2020) Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan. Cancer Sci 111:2156\u20132162","journal-title":"Cancer Sci"},{"key":"2411_CR16","unstructured":"Response to Routine Vaccination for Human Papillomavirus Infection 2021. The Ministry of Health, Labor and Welfare, Japan. Available online: https:\/\/www.mhlw.go.jp\/content\/000875155.pdf (accessed on 25 March 2023)."},{"key":"2411_CR17","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1016\/j.vaccine.2023.03.061","volume":"41","author":"M Machida","year":"2023","unstructured":"Machida M, Inoue S (2023) Patterns of HPV vaccine hesitancy among catch-up generations in Japan: A descriptive study. Vaccine 41:2956\u20132960","journal-title":"Vaccine"},{"key":"2411_CR18","unstructured":"Ministry of Education, Culture, Sports, Science and Technology, Statistical abstract : education, culture, sports, science and technology 2023, Available online: https:\/\/www.mext.go.jp\/b_menu\/toukei\/002\/002b\/1417059_00008.htm (accessed on 23 July 2023)"},{"key":"2411_CR19","unstructured":"Economic Research Office, ICT Strategy Policy Division, Information and Communications Bureau, Ministry of Internal Affairs and Communications, Japan, Information and Communications in Japan, WHITE PAPRE 2022, Available online: https:\/\/www.soumu.go.jp\/menu_seisaku\/hakusyo\/index.html (accessed on 23 July 2023)"},{"key":"2411_CR20","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/cas.15748","volume":"114","author":"Y Watanabe","year":"2023","unstructured":"Watanabe Y, Ueda Y, Yagi A et al (2023) Disparities among Japanese municipalities in recommendations for routine and catch-up HPV vaccinations. Cancer Sci 114:2139\u20132144. https:\/\/doi.org\/10.1111\/cas.15748","journal-title":"Cancer Sci"},{"key":"2411_CR21","unstructured":"Japan Family Planning Association, 7th Survey on the Lives and Attitudes of Men and Women. 2014. Available online: https:\/\/www.jfpa.or.jp\/paper\/main\/000047.html (accessed on 25 March 2023)."},{"key":"2411_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jadohealth.2005.06.004","volume":"37","author":"GD Zimet","year":"2005","unstructured":"Zimet GD, Perkins SM, Sturm LA et al (2005) Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Health 37:179\u2013186. https:\/\/doi.org\/10.1016\/j.jadohealth.2005.06.004","journal-title":"J Adolesc Health"},{"key":"2411_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jadohealth.2009.04.021","volume":"45","author":"R Caskey","year":"2009","unstructured":"Caskey R, Lindau ST, Alexander GC (2009) Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 45:453\u2013462. https:\/\/doi.org\/10.1016\/j.jadohealth.2009.04.021","journal-title":"J Adolesc Health"},{"key":"2411_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.socscimed.2009.05.024","volume":"69","author":"PL Reiter","year":"2009","unstructured":"Reiter PL, Brewer NT, Gottlieb SL et al (2009) Parents\u2019 health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 69:475\u2013480. https:\/\/doi.org\/10.1016\/j.socscimed.2009.05.024","journal-title":"Soc Sci Med"},{"key":"2411_CR25","doi-asserted-by":"crossref","unstructured":"Rahman M, Laz TH, McGrath CJ, Berenson AB (2015) Provider recommendation mediates the relationship between parental human papillomavirus (HPV) vaccine awareness and HPV vaccine initiation and completion among 13- to 17-year-old U.S. adolescent children, Clin Pediatr, 54: 371\u2013375","DOI":"10.1177\/0009922814551135"},{"key":"2411_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/0009922812468208","volume":"52","author":"C Dorell","year":"2013","unstructured":"Dorell C, Yankey D, Kennedy A et al (2013) Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey-Teen, 2010. Clin Pediatr (Phila) 52:162\u2013170. https:\/\/doi.org\/10.1177\/0009922812468208","journal-title":"Clin Pediatr (Phila)"},{"key":"2411_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2105\/AJPH.2011.300600","volume":"103","author":"KR Ylitalo","year":"2013","unstructured":"Ylitalo KR, Lee H, Mehta NK (2013) Health care provider recommendation, human papillomavirus vaccination, and race\/ethnicity in the US National Immunization Survey. Am J Public Health 103:164\u2013169. https:\/\/doi.org\/10.2105\/AJPH.2011.300600","journal-title":"Am J Public Health"},{"key":"2411_CR28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.18865\/ed.30.4.661","volume":"30","author":"AB Khodadadi","year":"2020","unstructured":"Khodadadi AB, Redden DT, Scarinci IC (2020) HPV Vaccination hesitancy among latina immigrant mothers despite physician recommendation. Ethn Dis 30:661\u2013670. https:\/\/doi.org\/10.18865\/ed.30.4.661","journal-title":"Ethn Dis"},{"key":"2411_CR29","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S0140-6736(20)31558-0","volume":"396","author":"A de Figueiredo","year":"2020","unstructured":"de Figueiredo A, Simas C, Karafillakis E et al (2020) Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet 396:898\u2013908. https:\/\/doi.org\/10.1016\/S0140-6736(20)31558-0","journal-title":"Lancet"},{"key":"2411_CR30","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","volume":"33","author":"MacDonald NE; SAGE Working Group on Vaccine Hesitancy","year":"2015","unstructured":"MacDonald NE; SAGE Working Group on Vaccine Hesitancy (2015) Vaccine hesitancy: definition, scope and determinants. Vaccine 33:4161\u20134164. https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.036","journal-title":"Vaccine"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02411-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-023-02411-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02411-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T04:30:56Z","timestamp":1701318656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-023-02411-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,30]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2411"],"URL":"https:\/\/doi.org\/10.1007\/s10147-023-02411-0","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,30]]},"assertion":[{"value":"9 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AY, YU, SI, and EM have received a lecture fee from Merck Sharp & Dohme (MSD). TK has received lecture fees and a research fund (Grant number J550703673) from MSD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained by an opt-out method. This study was approved by the Ethics Committee of the Osaka University Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent and ethical approval"}}]}}